60 Degrees Pharmaceuticals announced a private placement offering of 574,713 shares and warrants at $1.74 each, expected to raise about $1 million before fees. The offering includes series A and B warrants exercisable at $1.49 per share, with expiration terms of five years and two years respectively. Proceeds will support working capital and general corporate purposes. The company specializes in medicines for vector-borne diseases and has FDA-approved malaria prevention drug ARAKODA® available in the US and Australia.
Public Policy Holding Company, Inc. (PPHC) has acquired Reevemark LLC, a New York-based strategic communications firm specializing in litigation, crisis, and shareholder activism, for up to $80 million. This acquisition enhances PPHC's capabilities i...
New research by The Allstate Foundation of Canada shows that while 75% of Canadians have experienced or know someone who has experienced domestic abuse, only 9% recognize financial abuse as a form of it. However, 56% of abuse survivors identified fin...
Investec Bank plc, acting as joint broker for Pollen Street Group Limited, disclosed its share dealings on October 30, 2026. The bank purchased 4,503 ordinary shares and sold 1,946 ordinary shares at prices between 911 and 916 per unit. There were no...
Man Group PLC has publicly disclosed holding a 5.42% interest in Vesuvius plc's ordinary shares as of October 30, 2026. The disclosure includes details of cash-settled derivative transactions that slightly reduce their long position. This filing is p...
Investec Bank Plc, acting as advisor and joint broker to Advanced Medical Solutions Group Plc, disclosed its share dealings on October 30, 2026. The bank purchased 15,380 ordinary shares at a price of 282.75 per share and sold 201 shares at 283 each....
